Condition: Hypoxemic Respiratory Failure · Sponsor: University Hospital, Brest
The goal of this clinical trial is to validate the interest of a strategy adjusting the flow rate delivered under high-flow oxygen (HFO) therapy according to the lung volumes measured by a new technique, in intensive care patients with hypoxemic respiratory distress (HRD). The main question it aims to answer is: "The use of a technique of measurement of lung pulmonary with adjustement to the flow rate can make it possible to limite intubation in patients with HRD in intensive care?" The participants will be the patients admitted in intensive care for HRD with the need for treatment with HFO. This participants will be randomized in : * the arm control: treated by high flow oxygen therapy according to standard procedures. * or in the experimental arm : treated by high flow oxygen therapy with adjustement of ventilatory parametres based on lung volume measurements, obtained by the depth camera.
This description comes directly from the study's public registry record.
Laetitia BODENES, Dr · +33 2 30 33 76 78 · laetitia.bodenes@chu-brest.fr
Always discuss trial participation with your own doctor first.
| Brest, University Hospital | Brest, France | Recruiting |
| AP-HP - Hôpital Louis Mourier | Colombes, France | Not Yet Recruiting |
| AP-HP - Hôpital Henri Mondor | Créteil, France | Not Yet Recruiting |
| CH Morlaix | Morlaix, France | Not Yet Recruiting |
| CHR Orléans | Orléans, France | Not Yet Recruiting |
| CH Poitiers | Poitiers, France | Not Yet Recruiting |
| CHU Rennes | Rennes, France | Not Yet Recruiting |
| CHU Tours | Tours, France | Not Yet Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06819644